Navigation Links
InfoSpi to Create $500m Green Hedge Fund Focusing on the Carbon Credit Market

FT. LAUDERDALE, Fla., Jan. 15 /PRNewswire-FirstCall/ -- InfoSpi (OTC Bulletin Board: ISPI) are to create a Green Hedge Fund to provide further investment for the company's growth in the coming years.

"Taking carbon credit trading to a new level" is how CEO Chris Hamilton views this decision. "Funding change is the fundamental ethos behind this program."

As controlling and ultimately reducing Carbon Emissions feature so highly on the agenda of every Government, the demand for Carbon Offset Credits will grow. It is here that InfoSpi see a niche to generate investment revenue to support growth in their business.

Newly appointed Prince Carlos, who is heading up the fund stated, "We will fund the development of our projects from the revenue generated by the sale of the carbon credits that we have created by our technology for companies that need them to offset their emissions, almost like a closed loop." "This differentiates us from other hedge funds, as we control the production of the CO2 credits and therefore channelling the carbon 'tax' back as a solution to the problem. Of course the ultimate goal is to bring about change in how we capture and eliminate the emissions from our industrial demands."

A brief overview of the carbon trading market will tell the investors in InfoSpi that this may well present a very sound move. The New York Times recently reported that Carbon trading is one of the "fastest-growing specialties in financial services," and companies are scrambling to get a slice of the market now worth well over 100 billion and that could grow to $1 trillion within a decade.

Safe Harbor Statement

This press release contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of InfoSpi Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully, and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

SOURCE InfoSpi Inc.



SOURCE InfoSpi Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
2. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
3. Florida Childrens Hospital and Disney Unite to Create Magical Pediatric Hospital
4. Abbott Scientists Create One Molecule With Two Antibody Functions
5. Scientists create colorful brainbow images of the nervous system
6. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
7. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
8. Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies
9. Nikon Instruments Partners With Koshland Science Museum to Create the Museums First-Ever Microbe Lab
10. Stemagen First to Create Cloned Human Embryos From Adult Cells
11. Venter Institute Scientists Create First Synthetic Bacterial Genome
Post Your Comments:
(Date:11/25/2015)... , November 26, 2015 ... Global Biobanking Market 2016 - 2020 report analyzes ... maintaining integrity and quality in long-term samples, minimizing ... long-term cost-effectiveness. Automation minimizes manual errors such as ... technical efficiency. Further, it plays a vital role ...
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... in cat and human plaque and pave the way for ... health problems in cats     ... the most commonly diagnosed health problems in cats, yet relatively ... until now. Two collaborative studies have been conducted by researchers ...
(Date:11/25/2015)... Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... business and prospects remain fundamentally strong and highlights ... doxorubicin) recently received DSMB recommendation to continue the ... review of the final interim efficacy and safety ... Endpoint in men with heavily pretreated castration- and ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
Breaking Biology Technology:
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig Venter ... titled, "DNA Synthesis and Biosecurity: Lessons Learned and Options ... of Health and Human Services guidance for synthetic biology ... --> --> ... has the potential to pose unique biosecurity threats. It ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
Breaking Biology News(10 mins):